Azepane derivatives and methods of treating hepatitis B infections

A compound of Formula V:

• or a pharmaceutically acceptable salt thereof;
• wherein
• each R1 is, independently at each occurrence, halo, OH, —C1-C6 alkyl, or —O—C1-C6 alkyl, wherein the alkyl group is optionally substituted 1-3 times with halo or OH;
• each R2 is, independently at each occurrence, halo, OH, —C1-C6 alkyl, or —O—C1-C6 alkyl, wherein the alkyl group is optionally substituted 1-3 times with halo or OH;
• Cy is
• R11 is, independently at each occurrence, —OH, —C1-C6 alkyl, —OC(O)CH3, or —C3-C10 cycloalkyl;
• R13 and R14, together with the carbons to which they are attached, join to form a cyclopropyl ring;
• m is 1, 2, or 3;
• n is 1, 2, or 3;
• and
• x is 2 or 3.